Holen Sie sich die Stockscreener-App
1.36
0.73%
-0.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PETS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$1.37
Offen:
$1.36
24-Stunden-Volumen:
185.18K
Relative Volume:
0.92
Marktkapitalisierung:
$29.48M
Einnahmen:
$179.02M
Nettoeinkommen (Verlust:
$-57.29M
KGV:
-0.4948
EPS:
-2.7487
Netto-Cashflow:
$-33.01M
1W Leistung:
-11.11%
1M Leistung:
-27.08%
6M Leistung:
-40.61%
1J Leistung:
-47.69%
1-Tages-Spanne:
$1.33
$1.37
1-Wochen-Bereich:
$1.33
$1.53
52-Wochen-Spanne:
$1.33
$4.10
Petmed Express Inc Stock (PETS) Company Profile
Firmenname
Petmed Express Inc
Sektor
Branche
Telefon
(561) 426-4444
Adresse
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, MEDS, POM, SCNX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
1.36 | 33.17M | 179.02M | -57.29M | -33.01M | -2.7487 |
HITI
High Tide Inc
|
2.63 | 248.71M | 486.49M | -33.29M | 10.86M | -0.3627 |
MEDS
Trxade Health Inc
|
3.68 | 9.94M | 7.15M | 4.03M | -11.33M | -5.40 |
POM
Pomdoctor Ltd Adr
|
0.86 | 9.64M | 0 | 0 | 0 | 0.00 |
SCNX
Scienture Holdings Inc
|
0.1588 | 11.39M | 656.60K | -16.79M | -11.12M | -1.0743 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-25 | Eingeleitet | Lake Street | Buy |
| 2022-01-20 | Hochstufung | Sidoti | Neutral → Buy |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Underweight |
| 2021-10-01 | Eingeleitet | Jefferies | Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-06-03 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-03-05 | Hochstufung | Sidoti | Neutral → Buy |
| 2021-01-27 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-19 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-03-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-02-24 | Herabstufung | Sidoti | Buy → Neutral |
| 2019-08-16 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-06-15 | Eingeleitet | CL King | Neutral |
| 2017-08-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2017-07-24 | Hochstufung | Northcoast | Neutral → Buy |
| 2016-05-09 | Hochstufung | Craig Hallum | Sell → Hold |
| 2016-02-04 | Eingeleitet | Credit Suisse | Underperform |
| 2010-07-19 | Herabstufung | CL King | Strong Buy → Accumulate |
| 2010-07-19 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-05-25 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-05-06 | Bestätigt | Wedbush | Neutral |
| 2010-03-23 | Herabstufung | Janney Mntgmy Scott | Buy → Neutral |
| 2010-03-18 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2010-02-16 | Bestätigt | CL King | Strong Buy |
| 2009-07-21 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2009-01-07 | Eingeleitet | CL King | Strong Buy |
Alle ansehen
Petmed Express Inc Aktie (PETS) Neueste Nachrichten
Cash flow from operating activities of PetMed Express, Inc. – HAN:PQM - TradingView
PetMed Express CEO Jeffrey Willard Granted 500,000 Shares in Equity Awards - kalkinemedia.com
PetMed Express CEO Jeffrey Allen Willard Files Initial SEC Ownership Disclosure - kalkinemedia.com
A 250,000-share restricted award goes to PetMed Express (PETS) CEO. Another grant hinges on returns. - Stock Titan
Jeffrey Allen Willard, CEO and president of PetMed Express (PETS), is named in an initial ownership report. - Stock Titan
PetMed Express stock gets a new CEO after a 500,000-share plan - AD HOC NEWS
PetMed Express Files to Register 1.8 Million Additional Shares Under Updated 2024 Incentive Plan - kalkinemedia.com
PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan - TradingView
PetMed Express Is Maintained at Underweight by Morgan Stanley - Moomoo
PETS Maintains Rating by Morgan Stanley -- Price Target Lowered to $1.40 - GuruFocus
Form 8K PetMed Express Inc For: 22 September By Investing.com - Investing.com Australia
PetMed Express Q2 2026 Earnings: Reported Loss of $0.28 Per Share Swings Sharply Below ConsensusRevenue Breakdown Analysis - siam.in
PETMED EXPRESS INC (NASDAQ: PETS) Appoints Tamar Elkeles, Expanding Board to Five Directors - kalkinemedia.com
PetMed Express stock gains as new director joins board and governance roles - AD HOC NEWS
PetMed Express appoints Tamar Elkeles to board of directors By Investing.com - Investing.com Nigeria
PetMed Express appoints Tamar Elkeles to board of directors - Investing.com
PetMeds Appoints Tamar Elkeles to Board Amid Leadership Transition - citybiz
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director - The Manila Times
Qualcomm’s former talent chief joins PetMeds’ board - Stock Titan
PetMed Express Names Jeff Willard CEO Amid Transformation - The Globe and Mail
PetMed (PETS) Stock Analysis: -0.63% Loss — Key Levels 2026-09-17Large Cap Trends - careplusvn.com
PetMeds names Jeff Willard as CEO, Campbell to retire By Investing.com - Investing.com Australia
PetMeds names Jeff Willard as CEO, Campbell to retire - Investing.com
PetMeds Names Jeff Willard CEO as Justin Mennen Becomes Board Chair - citybiz
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition - The Manila Times
PetMeds will get a new CEO Sept. 28 as its board chair retires - Stock Titan
PetMeds Names Andrew Parry CTO to Lead E-Commerce and Pharmacy Technology - citybiz.co
PetMeds Appoints Andrew Parry as Chief Technology Officer - The Manila Times
PetMed Express names Andrew Parry as chief technology officer By Investing.com - Investing.com Australia
PetMed Express names Andrew Parry as chief technology officer - Investing.com
PetMed Express, Inc. Announces Appointment of Andrew Parry to Chief Technology Officer, Effective September 14, 2026 - marketscreener.com
PetMed Express, Inc. (PETS) Stock Price & News - Syfe
PetMed Express Inc. (PETS) Peer Comparison – Compare with Others - Value Research
PetMed Express Inc. (PETS) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
PetMed Express Inc. (PETS) Key Financial Ratios – Valuation, Profitability & More - Value Research
PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeVolume Dry Up - vinanet.vn
PetMed Express Inc. (PETS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PetMeds (PETS) Q1 FY2027 Results Show Stabilizing Revenue but No Margin Relief Yet - AlphaStreet
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - AOL.com
Petwealth and Kennel Connection Accelerate Partnership Following Strong Industry Response at SuperZoo 2026 - AOL.com
PetMed (PETS) Financial Update: EPS Falls Short of Its Estimate at the Close; After Earnings: The Stock Loses 1.67% in Latest TradingShare Repurchase Impact - vinanet.vn
150-year-old Cheltenham pharmacy rescued from administration - AOL.co.uk
Petmed Express Inc (PETS) Stock News Today - TradingKey
Full Transcript: PetMed Express Q1 2027 Earnings Call - Sahm
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y - Yahoo Finance
PetMed Express Q1 2027 Earnings Call Transcript - MarketBeat
PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million - TradingKey
PetMeds® Announces First Quarter Financial Results - The Manila Times
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express earnings missed by $0.40, revenue fell short of estimates - Investing.com Canada
PetMed Express, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Finanzdaten der Petmed Express Inc-Aktie (PETS)
Umsatz
Nettogewinn
Free Cashflow
ENV
9.36%
2.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):